2 months Best Momentum Stocks to Buy for January 6th Zacks

   X     

2 months Amphastar Pharmaceuticals: Cheap With Caveats Seeking Alpha

   X     

2 months Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Moves to Buy: Rationale Behind the Upgrade Zacks

   X     

2 months Jefferies starts Rhythm Pharmaceuticals with Buy on obesity potential Yahoo Finance

   X     

2 months Crinetics Pharmaceuticals: Attractive Speculative Bet On Market Weakness Seeking Alpha

   X     

2 months Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report? Zacks

   X     

2 months Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year? Zacks

   X     

2 months Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know Zacks

   X     

2 months Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors Zacks

   X     

2 months Vertex Pharmaceuticals: Jim Cramer Fires A Warning Shot But I Remain Invested Seeking Alpha

   X     

2 months Wedbush starts Rocket Pharmaceuticals with Outperform into ‘inflection year’ Yahoo Finance

   X     

2 months Marinus Pharmaceuticals to be acquired by Immedica for 55c per share Yahoo Finance

   X     

2 months Citius Pharmaceuticals upgraded to Buy from Hold at D. Boral Capital Yahoo Finance

   X     

2 months Centessa Pharmaceuticals: Orexin Franchise Worth Monitoring Seeking Alpha

   X     

2 months Rigel Pharmaceuticals: Realizing The Promise Of Its Acquired Pipeline Agents Seeking Alpha

   X     

2 months Is the Options Market Predicting a Spike in Vertex Pharmaceuticals (VRTX) Stock? Zacks

   X     

2 months Elite Pharmaceuticals Launches Generic Vyvanse for ADHD Market Yahoo Finance

   X     

2 months Telix Pharmaceuticals: Australian Company And A Solid Recent U.S. IPO Seeking Alpha

   X     

2 months All You Need to Know About ANI (ANIP) Rating Upgrade to Buy Zacks

   X     

2 months How Tarsus Pharmaceuticals’ Unique Inspiration Is Driving A Triple-Digit Run Investor's Business Daily

   X     

2 months The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex Zacks

   X     

2 months The Zacks Analyst Blog Highlights T-Mobile, Toyota Motor, Vertex Pharmaceuticals, BK Technologies and Servotronics Zacks

   X     

2 months NovaBay Pharmaceuticals (NBY) Upgraded to Buy: Here’s Why Zacks

   X     

2 months Mirum Pharmaceuticals: Buy At Dips For Volixibat Potential Seeking Alpha

   X     

2 months Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year? Zacks

   X     

2 months Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know Zacks

   X     

2 months Top Stock Reports for T-Mobile, Toyota Motor & Vertex Pharmaceuticals Zacks

   X     

2 months Vertex Pharmaceuticals price target lowered to $460 from $550 at Truist Yahoo Finance

   X     

2 months Anebulo Pharmaceuticals collaborates with FDA to advance selonabant Yahoo Finance

   X     

2 months Vertex Secures FDA Approval for New Cystic Fibrosis Drug Alyftrek Zacks

   X     

2 months Jazz Pharmaceuticals: Should Sing A Better Tune In 2025 Seeking Alpha

   X     

2 months Enanta Pharmaceuticals (ENTA) Moves 7.2% Higher: Will This Strength Last? Zacks

   X     

2 months Ionis Pharmaceuticals: Promising Growth From Tryngolza Approval Seeking Alpha

   X     

2 months Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? Zacks

   X     

2 months Is Recursion Pharmaceuticals Stock a Millionaire Maker? Yahoo Finance

   X     

2 months Vertex Pharmaceuticals price target lowered to $441 from $506 at Bernstein Yahoo Finance

   X     

2 months Vertex Wins An Early Approval; Why It Might Not Move Vertex’s Beleaguered Stock Investor's Business Daily

   X     

2 months Ironwood Pharmaceuticals shares surge on competitor’s woes Investing.com

   X     

2 months Rhythm Pharmaceuticals’ Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential Yahoo Finance

   X     

2 months Vanda Pharmaceuticals: Net-Net Status Presents A Trading Opportunity Seeking Alpha

   X     

2 months VRTX Down as Non-Opioid Drug Shows Similar Pain Reduction as Placebo Zacks

   X     

2 months Cramer’s Mad Dash: Vertex Pharmaceuticals YouTube

   X     

2 months Ionis Gets FDA Approval for Rare Disease Drug Tryngolza Zacks

   X     

2 months Cramer’s Stop Trading: Vertex Pharmaceuticals YouTube

   X     

2 months Vertex Non-Opioid Drug Doesn’t Best Placebo In Back Pain Study. The Stock Is Plunging. Investor's Business Daily

   X     

2 months Corvus Pharmaceuticals: Not Just A One-Hit Wonder In ITK Inhibitor Targeting Seeking Alpha

   X     

2 months REGN’s Eylea HD Shows Non-Inferiority to Eylea in Eye Disease Study Zacks

   X     

2 months Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? Zacks

   X     

2 months Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It Zacks

   X     

2 months SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study Zacks

   X